Find Terevalefim manufacturers, exporters & distributors on PharmaCompass

Terevalefim

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

DEVELOPMENTS

7 Drugs in Development

7 Drugs in Development

DIGITAL CONTENT

1 NEWS #PharmaBuzz

media
1 NEWS #PharmaBuzz

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

7DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: Terevalefim, Ang-3777, Terevalefim [inn], Terevalefim [usan], Snv-003, Gg91uxk2m5

Molecular Formula

C₉H₈N₂S

Molecular Weight

176.24 g/mol

InChI Key

FOHWAQGURRYJFK-ONEGZZNKSA-N

FDA UNII

GG91UXK2M5

Terevalefim is under investigation in clinical trial NCT02474667 (Reduce the Severity of DGF in Recipients of a Deceased Donor Kidney).

1 2D Structure

Terevalefim

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

5-[(E)-2-thiophen-2-ylethenyl]-1H-pyrazole

2.1.2 InChI

InChI=1S/C9H8N2S/c1-2-9(12-7-1)4-3-8-5-6-10-11-8/h1-7H,(H,10,11)/b4-3+

2.1.3 InChI Key

FOHWAQGURRYJFK-ONEGZZNKSA-N

2.1.4 Canonical SMILES

C1=CSC(=C1)C=CC2=CC=NN2

2.1.5 Isomeric SMILES

C1=CSC(=C1)/C=C/C2=CC=NN2

2.2 Other Identifiers

2.2.1 UNII

GG91UXK2M5

2.3 Synonyms

2.3.1 MeSH Synonyms

1. Ang-3777

2. Snv-003

3. Terevalefim

2.3.2 Depositor-Supplied Synonyms

1. Terevalefim

2. Ang-3777

3. Terevalefim [inn]

4. Terevalefim [usan]

5. Snv-003

6. Gg91uxk2m5

7. 1070881-42-3

8. 500128-99-4

9. 5-((e)-2-thiophen-2-yl-vinyl)-lh-pyrazole

10. 1h-pyrazole, 3-((1e)-2-(2-thienyl)ethenyl)-

11. Bb3

12. Unii-gg91uxk2m5

13. 5-[(e)-2-thiophen-2-ylethenyl]-1h-pyrazole

14. Terevalefim [who-dd]

15. Bb-3

16. Schembl1225335

17. Chembl4650326

18. Schembl10149623

19. Gtpl11997

20. Ang3777

21. Zinc4301780

22. Who 11458

23. 3-[2-(2-thienyl)ethenyl]-1h-pyrazole

24. Hy-137455

25. Cs-0138662

26. (e)-5-(2-(thiophen-2-yl)vinyl)-1h-pyrazole

27. E80357

28. (e)-3-(2-(thiophen-2-yl)vinyl)-1h-pyrazole

2.4 Create Date

2005-07-19

3 Chemical and Physical Properties

Molecular Formula	C₉H₈N₂S
Molecular Weight	176.24 g/mol
XLogP3	2.2
Hydrogen Bond Donor Count	1
Hydrogen Bond Acceptor Count	2
Rotatable Bond Count	2
Exact Mass	176.04081944 g/mol
Monoisotopic Mass	176.04081944 g/mol
Topological Polar Surface Area	56.9 Å²
Heavy Atom Count	12
Formal Charge	0
Complexity	170
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	1
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

4 Pharmacology and Biochemistry

4.1 Mechanism of Action

Terevalefim, a small molecule developed by Angion Biomedica Corp., mimics the activity of hepatocyte growth factor (HGF). Through its actions, it activates the c-Met cascade, exhibits c-Met dependence and c-Met receptor activation. As it is able to activate repair pathways, it has been tested in clinical trials for acute kidney injury and in delayed graft function. As of July 2020, Angion has announced a Phase 2 proof-of-concept trial to invesigate terevalefim on preventing and mitigating lung injury in patients with COVID-19 (NCT04459676).

Drugs in Development